Question: what do celgene shareholders get?
Answer: Under the terms of the acquisition deal, which brings together two of biopharma's largest players in the oncology space, Celgene shareholders will receive $50 in cash, one Bristol-Myers share and one tradeable contingent value right for each share of Celgene.